Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program

Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture

Gerritdina J. Huisman, Bart C.J.M. Fauser, Marinus J.C. Eijkemans et al. · Fertility and Sterility · 2000 · 177 citations

Veterinary Medicine, Developmental Biology, Obstetrics +11

Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates

Belen Acevedo, José Luis Gómez-Palomares, Elisabetta Ricciarelli et al. · Fertility and Sterility · 2006 · 147 citations · Full text

Medicine, Gynecology, Obstetrics +14

Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles

Georg Griesinger, Efstratios M. Κolibianakis, Evangelos Papanikolaou et al. · Fertility and Sterility · 2007 · 105 citations · Full text

Life Sciences, Endocrinology, Gynecology +11

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

Nikos Prapas, Yannis Prapas, Yannis Panagiotidis et al. · Human Reproduction · 2005 · 58 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +13

Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial

Daniel Bodri · Human Reproduction · 2006 · 38 citations · Full text

Medicine, Endocrinology, Gynecology +14